NCT03270189

Brief Summary

Cervical dystonia occurring only during the writing task is a rare form for which there is no established treatment. Many authors agree that alteration of sensory integration is associated with dystonia. Similar disturbances in the integration of oculomotor information could have a role in cervical dystonia forms involving visuo-cervico-manual coordination such as handwriting. We hypothesize that orthoptic treatment by wearing prisms when writing (i) will reduce the abnormal posture of the head occurring whilst writing and remove the associated nuchal pain; (ii) the correction after a period of systematic wearing of the prisms during handwriting tasks will have a sustainable effect allowing to keep a normal head position after the suppression of the prisms.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 1, 2017

Completed
17 days until next milestone

Study Start

First participant enrolled

September 18, 2017

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 19, 2022

Completed
Last Updated

February 14, 2023

Status Verified

February 1, 2023

Enrollment Period

4.3 years

First QC Date

August 29, 2017

Last Update Submit

February 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • measure of head movement occurring when writing

    Difference of the angle measured with and without corrective prisms during the handwriting tasks

    3 months

Study Arms (2)

orthoptic treatment

EXPERIMENTAL

Patients with cervical dystonia occuring only during handwriting.

Device: prism glasses

Controls

NO INTERVENTION

Patients without cervical dystonia.

Interventions

orthoptic treatment by wearing prisms when writing

orthoptic treatment

Eligibility Criteria

Age18 Years - 71 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Case
  • Presenting a cervical dystonia that occurs only during handwriting tasks, diagnosed by a neurologist specialised in movement disorders
  • Being treated or not by injection of Botulinum Neurotoxin (but last injection \> 3 months before the initial assessment)
  • Control
  • No cervical dystonia
  • Same sex, age (± 5 years), socio-professional level and hand laterality as the cases

You may not qualify if:

  • Case
  • Cervical dystonia occuring in other circumstances than handwriting
  • Neurological disease other than cervical dystonia (e.g. Parkinson's syndrome)
  • Pain, trauma or pathology of the cervical spine of another cause than cervical dystonia and which have required medical or surgical treatment in the last 6 months preceding the initial assessment
  • Control
  • Cervical disorders requiring medical or surgical treatment in the last 6 months prior to the tests
  • Neurological disease affecting the cervical region or the writing hand
  • Uncorrected visual disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Ophtalmique Adolphe de Rothschild

Paris, 75019, France

Location

MeSH Terms

Conditions

DystoniaDystonic DisordersTorticollisMovement DisordersCentral Nervous System DiseasesNervous System DiseasesDyskinesiasNeurologic Manifestations

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jean-Pierre Bleton, PhD

    Fondation Ophtalmologique Adolphe de Rothschild

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2017

First Posted

September 1, 2017

Study Start

September 18, 2017

Primary Completion

December 19, 2021

Study Completion

September 19, 2022

Last Updated

February 14, 2023

Record last verified: 2023-02

Locations